{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:12:58Z","timestamp":1778760778416,"version":"3.51.4"},"reference-count":70,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["JP21H04865"],"award-info":[{"award-number":["JP21H04865"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Long-term intake of Collagen Tripeptide (CTP), which is rich in Glycine-\nX-Y sequences, improves blood vessel elasticity and reduces the serum levels of cytotoxic\nglyceraldehyde (GA)-derived Advanced Glycation End-Products (AGEs), also known as Toxic\nAGEs (TAGE). Therefore, the anti-glycation effect of CTP may be one of the mechanisms\ncontributing to its ability to improve vascular elasticity. This study aims to investigate the antiglycation\neffects of the tripeptide, glycine-proline-hydroxyproline (Gly-Pro-Hyp; GPHyp), the main\ncomponent of CTP, using in vitro GA glycation models and comparing its metabolite sequences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Cell viability and mRNA expression were measured in GA-treated HepG2 cells with or\nwithout the addition of GPHyp. The half-maximal inhibitory concentration (IC50) of GPHyp for\ninhibiting TAGE formation and for inhibiting lysozyme glycation crosslinking was evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Only GPHyp significantly suppressed cell death and interleukin-8 (IL-8) mRNA\nexpression in GA-treated cells. The IC50 for TAGE production and inhibitory effect on lysozyme\ncrosslinking demonstrated that GPHyp exhibited stronger anti-glycation effects than its metabolite\namino acids and peptides. The addition of GPHyp also resulted in increased GA consumption.\nAnalysis of the changes in GA concentrations during the reaction revealed that the addition of\nGPHyp significantly reduced GA levels within the first hour.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>These results suggest that GPHyp possesses potent GA-scavenging activity and inhibits\nTAGE production, contributing to the CTP-mediated reduction in serum TAGE levels and to\nimprovements in vascular elasticity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The anti-glycation effect of GPHyp may support a healthy lifestyle and warrant further\ninvestigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298665432008260403055737","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T11:56:06Z","timestamp":1777550166000},"page":"454-464","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Glycine-Proline-Hydroxyproline Tripeptide Reduces Cell Death Caused by Glycative Stress"],"prefix":"10.2174","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7392-7232","authenticated-orcid":true,"given":"Shoko","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Technical Center, Jellice Co., Ltd., 4-4-1 Sakae, Tagajo, Miyagi 985-0833, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7139-8824","authenticated-orcid":true,"given":"Yo","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Technical Center, Jellice Co., Ltd., 4-4-1 Sakae, Tagajo, Miyagi 985-0833, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiro","family":"Yanbe","sequence":"additional","affiliation":[{"name":"Technical Center, Jellice Co., Ltd., 4-4-1 Sakae, Tagajo, Miyagi 985-0833, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1258-1725","authenticated-orcid":true,"given":"Akiko","family":"Sakai-Sakasai","sequence":"additional","affiliation":[{"name":"Department of Advanced Medicine,Medical Research Institute, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Kahoku, Ishikawa 920-0293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1057-3764","authenticated-orcid":true,"given":"Masayoshi","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Advanced Medicine,Medical Research Institute, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Kahoku, Ishikawa 920-0293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4624-9867","authenticated-orcid":true,"given":"Noriaki","family":"Numata","sequence":"additional","affiliation":[{"name":"Technical Center, Jellice Co., Ltd., 4-4-1 Sakae, Tagajo, Miyagi 985-0833, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1042\/bj3500381","volume":"350","author":"Verzijl N.","year":"2000","unstructured":"Verzijl N.; Degroot J.; Oldehinkel E.; Bank R.A.; Thorpe S.R.; Baynes J.W.; Bayliss M.T.; Bijlsma J.W.J.; Lafeber F.P.J.G.; Tekoppele J.M.; Age-related accumulation of maillard reaction products in human articular cartilage collagen. Biochem J  2000,350(2),381-387","journal-title":"Biochem J"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1002\/1529-0131(200111)44:11<2562:AID-ART437>3.0.CO;2-1","volume":"44","author":"DeGroot J.","year":"2001","unstructured":"DeGroot J.; Verzijl N.; Wenting-Van Wijk M.J.G.; Bank R.A.; Lafeber F.P.J.G.; Bijlsma J.W.J.; TeKoppele J.M.; Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: The role of advanced glycation end products. Arthritis Rheum  2001,44(11),2562-2571","journal-title":"Arthritis Rheum"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"6743","DOI":"10.1038\/s41467-021-26982-6","volume":"12","author":"Di Sanzo S.","year":"2021","unstructured":"Di Sanzo S.; Spengler K.; Leheis A.; Kirkpatrick J.M.; R\u00e4ndler T.L.; Baldensperger T.; Dau T.; Henning C.; Parca L.; Marx C.; Wang Z.Q.; Glomb M.A.; Ori A.; Heller R.; Mapping protein carboxymethylation sites provides insights into their role in proteostasis and cell proliferation. Nat Commun  2021,12(1),6743","journal-title":"Nat Commun"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12551-024-01188-4","volume":"16","author":"Uceda A.B.","year":"2024","unstructured":"Uceda A.B.; Mari\u00f1o L.; Casasnovas R.; Adrover M.; An overview on glycation: Molecular mechanisms, impact on proteins, pathogenesis, and inhibition. Biophys Rev  2024,16(2),189-218","journal-title":"Biophys Rev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/3818196","volume":"2020","author":"Perrone A.","year":"2020","unstructured":"Perrone A.; Giovino A.; Benny J.; Martinelli F.; Advanced glycation end products (AGEs): Biochemistry, signaling, analytical methods, and epigenetic effects. Oxid Med Cell Longev  2020,2020,1-18","journal-title":"Oxid Med Cell Longev"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s001250051591","volume":"44","author":"Singh R.","year":"2002","unstructured":"Singh R.; Barden A.; Mori T.; Beilin, L Advanced glycation end-products: A review. Diabetologia  2002,44(2),293","journal-title":"Diabetologia"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"vvaf119","DOI":"10.1093\/ijfood\/vvaf119","volume":"60","author":"Gan L.","year":"2025","unstructured":"Gan L.; Du X.; Wei Y.; Hu Z.; Sources of advanced glycation end products in the human body: a mini review. Int J Food Sci Technol  2025,60(1),vvaf119","journal-title":"Int J Food Sci Technol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2337\/dc14-1435","volume":"38","author":"Kajikawa M.","year":"2015","unstructured":"Kajikawa M.; Nakashima A.; Fujimura N.; Maruhashi T.; Iwamoto Y.; Iwamoto A.; Matsumoto T.; Oda N.; Hidaka T.; Kihara Y.; Chayama K.; Goto C.; Aibara Y.; Noma K.; Takeuchi M.; Matsui T.; Yamagishi S.; Higashi Y.; Ratio of serum levels of AGEs to soluble form of RAGE is a predictor of endothelial function. Diabetes Care  2015,38(1),119-125","journal-title":"Diabetes Care"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1359255","DOI":"10.3389\/fendo.2024.1359255","volume":"15","author":"Yang D.R.","year":"2024","unstructured":"Yang D.R.; Wang M.Y.; Zhang C.L.; Wang Y.; Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications. Front Endocrinol (Lausanne)  2024,15,1359255","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1540\/jsmr.57.94","volume":"57","author":"Matsumoto T.","year":"2021","unstructured":"Matsumoto T.; Taguchi K.; Kobayashi T.; Relationships between advanced glycation end products (AGEs), vasoactive substances, and vascular function. J Smooth Muscle Res  2021,57(0),94-107","journal-title":"J Smooth Muscle Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1186\/s40001-023-01431-w","volume":"28","author":"Liu J.","year":"2023","unstructured":"Liu J.; Pan S.; Wang X.; Liu Z.; Zhang Y.; Role of advanced glycation end products in diabetic vascular injury: molecular mechanisms and therapeutic perspectives. Eur J Med Res  2023,28(1),553","journal-title":"Eur J Med Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","volume":"114","author":"Goldin A.","year":"2006","unstructured":"Goldin A.; Beckman J.A.; Schmidt A.M.; Creager M.A.; Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation  2006,114(6),597-605","journal-title":"Circulation"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1755-5922.2011.00264.x","volume":"30","author":"Ueda S.","year":"2012","unstructured":"Ueda S.; Yamagishi S.; Matsui T.; Noda Y.; Ueda S.; Jinnouchi Y.; Sasaki K.; Takeuchi M.; Imaizumi T.; Serum levels of advanced glycation end products (AGEs) are inversely associated with the number and migratory activity of circulating endothelial progenitor cells in apparently healthy subjects. Cardiovasc Ther  2012,30(4),249-254","journal-title":"Cardiovasc Ther"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jdermsci.2011.06.015","volume":"64","author":"Ogura Y.","year":"2011","unstructured":"Ogura Y.; Kuwahara T.; Akiyama M.; Tajima S.; Hattori K.; Okamoto K.; Okawa S.; Yamada Y.; Tagami H.; Takahashi M.; Hirao T.; Dermal carbonyl modification is related to the yellowish color change of photo-aged Japanese facial skin. J Dermatol Sci  2011,64(1),45-52","journal-title":"J Dermatol Sci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"837222","DOI":"10.3389\/fmed.2022.837222","volume":"9","author":"Chen C.","year":"2022","unstructured":"Chen C.; Zhang J.Q.; Li L.; Guo M.; He Y.; Dong Y.; Meng H.; Yi F.; Advanced glycation end products in the skin: molecular mechanisms, methods of measurement, and inhibitory pathways. Front Med (Lausanne)  2022,9,837222","journal-title":"Front Med (Lausanne)"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"5596","DOI":"10.3390\/ijms25115596","volume":"25","author":"Fang B.","year":"2024","unstructured":"Fang B.; Li L.; Winget J.; Laughlin T.; Hakozaki T.; Identification of yellow advanced glycation end products in human skin. Int J Mol Sci  2024,25(11),5596","journal-title":"Int J Mol Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"e15065","DOI":"10.1111\/exd.15065","volume":"33","author":"Wang L.","year":"2024","unstructured":"Wang L.; Jiang Y.; Zhao C.; The effects of advanced glycation end\u2010products on skin and potential anti\u2010glycation strategies. Exp Dermatol  2024,33(4),e15065","journal-title":"Exp Dermatol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1177\/0022034516662246","volume":"95","author":"Matsuda Y.","year":"2016","unstructured":"Matsuda Y.; Miura J.; Shimizu M.; Aoki T.; Kubo M.; Fukushima S.; Hashimoto M.; Takeshige F.; Araki T.; Influence of nonenzymatic glycation in dentinal collagen on dental caries. J Dent Res  2016,95(13),1528-1534","journal-title":"J Dent Res"},{"key":"ref=19","first-page":"59","volume":"40","author":"Miura J.","year":"2021","unstructured":"Miura J.; Aging and glycation in teeth. J Gerodontology  2021,40(3),59-64","journal-title":"J Gerodontology"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/iej.13966","volume":"56","author":"Alsamahi S.","year":"2023","unstructured":"Alsamahi S.; Milne T.J.; Mohd Hussaini H.M.; Rich A.M.; Cooper P.R.; Friedlander L.T.; Effects of glycation end\u2010products on the dental pulp in patients with type 2 diabetes. Int Endod J  2023,56(11),1373-1384","journal-title":"Int Endod J"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00726-010-0778-x","volume":"42","author":"Nagaraj R.H.","year":"2012","unstructured":"Nagaraj R.H.; Linetsky M.; Stitt A.W.; The pathogenic role of Maillard reaction in the aging eye. Amino Acids  2012,42(4),1205-1220","journal-title":"Amino Acids"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"530","DOI":"10.5551\/jat.36293","volume":"24","author":"Tomosugi N.","year":"2017","unstructured":"Tomosugi N.; Yamamoto S.; Takeuchi M.; Yonekura H.; Ishigaki Y.; Numata N.; Katsuda S.; Sakai Y.; Effect of collagen tripeptide on atherosclerosis in healthy humans. J Atheroscler Thromb  2017,24(5),530-538","journal-title":"J Atheroscler Thromb"},{"key":"ref=23","first-page":"1595","volume":"48","author":"Yamamoto S.","year":"2020","unstructured":"Yamamoto S.; Matsumoto Y.; Numata N.; Sakai Y.; Okada T.; Effects of ingestion of collagen tripeptide on arteriosclerosis-A randomized, double-blind, placebo-controlled, parallel-group study. Jpn Pharmacol Ther  2020,48,1595-1605","journal-title":"Jpn Pharmacol Ther"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/diagnostics6020023","volume":"6","author":"Takeuchi M.","year":"2016","unstructured":"Takeuchi M.; Serum levels of toxic AGEs (TAGE) may be a promising novel biomarker for the onset\/progression of lifestyle-related diseases. Diagnostics (Basel)  2016,6(2),23","journal-title":"Diagnostics (Basel)"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.3390\/cells11142178","volume":"11","author":"Takeuchi M.","year":"2022","unstructured":"Takeuchi M.; Sakasai-Sakai A.; Takata T.; Takino J.; Koriyama Y.; Effects of toxic AGEs (TAGE) on human health. Cells  2022,11(14),2178","journal-title":"Cells"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1021\/jf9031487","volume":"58","author":"Watanabe-Kamiyama M.","year":"2010","unstructured":"Watanabe-Kamiyama M.; Shimizu M.; Kamiyama S.; Taguchi Y.; Sone H.; Morimatsu F.; Shirakawa H.; Furukawa Y.; Komai M.; Absorption and effectiveness of orally administered low molecular weight collagen hydrolysate in rats. J Agric Food Chem  2010,58(2),835-841","journal-title":"J Agric Food Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1080\/09168451.2015.1062711","volume":"79","author":"Yamamoto S.","year":"2015","unstructured":"Yamamoto S.; Hayasaka F.; Deguchi K.; Okudera T.; Furusawa T.; Sakai Y.; Absorption and plasma kinetics of collagen tripeptide after peroral or intraperitoneal administration in rats. Biosci Biotechnol Biochem  2015,79(12),2026-2033","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1248\/bpb.b15-00624","volume":"39","author":"Yamamoto S.","year":"2016","unstructured":"Yamamoto S.; Deguchi K.; Onuma M.; Numata N.; Sakai Y.; Absorption and urinary excretion of peptides after collagen tripeptide ingestion in humans. Biol Pharm Bull  2016,39(3),428-434","journal-title":"Biol Pharm Bull"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1021\/acs.jafc.6b05679","volume":"65","author":"Yazaki M.","year":"2017","unstructured":"Yazaki M.; Ito Y.; Yamada M.; Goulas S.; Teramoto S.; Nakaya M.; Ohno S.; Yamaguchi K.; Oral ingestion of collagen hydrolysate leads to the transportation of highly concentrated Gly-Pro-Hyp and its hydrolyzed form of Pro-Hyp into the bloodstream and skin. J Agric Food Chem  2017,65(11),2315-2322","journal-title":"J Agric Food Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/jmf.2022.K.0149","volume":"26","author":"Chae M.","year":"2023","unstructured":"Chae M.; Moon C.Y.; Lim S.H.; Yamashita Y.; Yamada H.; Ide M.; Park C.W.; Roh J.; Kim W.; Oral ingestion of AP collagen peptide leads to systemic absorption of Gly-Pro-Hyp, alleviating H2O2-induced dermal fibroblast aging. J Med Food  2023,26(5),299-306","journal-title":"J Med Food"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"7127","DOI":"10.1021\/acs.jafc.6b02955","volume":"64","author":"Sontakke S.B.","year":"2016","unstructured":"Sontakke S.B.; Jung J.; Piao Z.; Chung H.J.; Orally available collagen tripeptide: enzymatic stability, intestinal permeability, and absorption of Gly-Pro-Hyp and Pro-Hyp. J Agric Food Chem  2016,64(38),7127-7133","journal-title":"J Agric Food Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1126\/science.3487117","volume":"232","author":"Brownlee M.","year":"1986","unstructured":"Brownlee M.; Vlassara H.; Kooney A.; Ulrich P.; Cerami A.; Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science  1986,232(4758),1629-1632","journal-title":"Science"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.abb.2003.08.013","volume":"419","author":"Thornalley P.J.","year":"2003","unstructured":"Thornalley P.J.; Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch Biochem Biophys  2003,419(1),31-40","journal-title":"Arch Biochem Biophys"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"108488","DOI":"10.1016\/j.abb.2020.108488","volume":"691","author":"Rahbar S.","year":"2020","unstructured":"Rahbar S.; Figarola J.L.; Novel inhibitors of advanced glycation endproducts. Arch Biochem Biophys  2020,691,108488","journal-title":"Arch Biochem Biophys"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.3390\/molecules24152751","volume":"24","author":"Sadowska-Bartosz I.","year":"2019","unstructured":"Sadowska-Bartosz I.; Bartosz G.; Prevention of protein glycation by natural compounds. Molecules  2019,24(16),2751","journal-title":"Molecules"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000075627","volume":"24","author":"Bolton W.K.","year":"2004","unstructured":"Bolton W.K.; Cattran D.C.; Williams M.E.; Adler S.G.; Appel G.B.; Cartwright K.; Foiles P.G.; Freedman B.I.; Raskin P.; Ratner R.E.; Spinowitz B.S.; Whittier F.C.; Wuerth J.P.; for the ACTION I Investigator Group. Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. Am J Nephrol  2004,24(1),32-40","journal-title":"Am J Nephrol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1006\/exer.1993.1167","volume":"57","author":"Ramakrishnan S.","year":"1993","unstructured":"Ramakrishnan S.; Sulochana K.N.; Decrease in glycation of lens proteins by lysine and glycine by scavenging of glucose and possible mitigation of cataractogenesis. Exp Eye Res  1993,57(5),623-628","journal-title":"Exp Eye Res"},{"key":"ref=38","first-page":"439","volume":"18","author":"Bahmani F.","year":"2012","unstructured":"Bahmani F.; Bathaie S.Z.; Aldavood S.J.; Ghahghaei A.; Glycine therapy inhibits the progression of cataract in streptozotocin-induced diabetic rats. Mol Vis  2012,18,439-448","journal-title":"Mol Vis"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1039\/C7MD00514H","volume":"9","author":"Chilukuri H.","year":"2018","unstructured":"Chilukuri H.; Kulkarni M.J.; Fernandes M.; Revisiting amino acids and peptides as anti-glycation agents. MedChemComm  2018,9(4),614-624","journal-title":"MedChemComm"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1039\/c4ra11773e","volume":"5","author":"Moosavi-Movahedi A.A.","year":"2015","unstructured":"Moosavi-Movahedi A.A.; Ghamari F.; Ghaffari S.M.; Salami M.; Farivar F.; Moosavi-Movahedi F.; Johari A.L.N.; Natural peptide anti-glycation effect in the presence of aloe vera phenolic components on human serum albumin. RSC Adv  2015,5,248-254","journal-title":"RSC Adv"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.3390\/foods12112103","volume":"12","author":"Li L.","year":"2023","unstructured":"Li L.; Zhuang Y.; Zou X.; Chen M.; Cui B.; Jiao Y.; Cheng Y.; Advanced glycation end products: a comprehensive review of their detection and occurrence in food. Foods  2023,12(11),2103","journal-title":"Foods"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3390\/antiox14040492","volume":"14","author":"Zhang Y.","year":"2025","unstructured":"Zhang Y.; Zhang Z.; Tu C.; Chen X.; He R.; Advanced glycation end products in disease development and potential interventions. Antioxidants  2025,14(4),492","journal-title":"Antioxidants"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"6127","DOI":"10.1016\/j.sjbs.2021.06.063","volume":"28","author":"Alkahtani S.","year":"2021","unstructured":"Alkahtani S.; Alarifi S.; Alkahtane A.A.; Albasher G.; AL-Zharani, M.; Alhoshani, N.M.; AL-Johani, N.S.; Aljarba, N.H.; Saquib, H.M. Pyrroloquinoline quinone alleviates oxidative damage induced by high glucose in HepG2 cells. Saudi J Biol Sci  2021,28(11),6127-6132","journal-title":"Saudi J Biol Sci"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"111958","DOI":"10.1016\/j.biopha.2021.111958","volume":"142","author":"Drygalski K.","year":"2021","unstructured":"Drygalski K.; Fereniec E.; Zalewska A.; Kr\u0119towski A.; \u017bendzian-Piotrowska M.; Maciejczyk M.; Phloroglucinol prevents albumin glycation as well as diminishes ROS production, glycooxidative damage, nitrosative stress and inflammation in hepatocytes treated with high glucose. Biomed Pharmacother  2021,142,111958","journal-title":"Biomed Pharmacother"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2131\/jts.47.381","volume":"47","author":"Sawai M.","year":"2022","unstructured":"Sawai M.; Miyauchi Y.; Ishida T.; Takechi S.; Dihydropyrazine suppresses TLR4-dependent inflammatory responses by blocking MAPK signaling in human hepatoma HepG2 cells. J Toxicol Sci  2022,47(9),381-387","journal-title":"J Toxicol Sci"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"14282","DOI":"10.1038\/s41598-017-14711-3","volume":"7","author":"Sakasai-Sakai A.","year":"2017","unstructured":"Sakasai-Sakai A.; Takata T.; Takino J.; Takeuchi M.; Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death. Sci Rep  2017,7(1),14282","journal-title":"Sci Rep"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.3390\/ijms21144861","volume":"21","author":"Sakasai-Sakai A.","year":"2020","unstructured":"Sakasai-Sakai A.; Takata T.; Takeuchi M.; Intracellular toxic advanced glycation end-products promote the production of reactive oxygen species in HepG2 cells. Int J Mol Sci  2020,21(14),4861","journal-title":"Int J Mol Sci"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1248\/bpb.b21-00520","volume":"44","author":"Kikuchi C.","year":"2021","unstructured":"Kikuchi C.; Sakasai-Sakai A.; Okimura R.; Tanaka H.; Takata T.; Takeuchi M.; Matsunaga T.; Accumulation of toxic advanced glycation end-products induces cytotoxicity and inflammation in hepatocyte-like cells differentiated from human induced pluripotent stem cells. Biol Pharm Bull  2021,44(10),1399-1402","journal-title":"Biol Pharm Bull"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1177\/0960327120964543","volume":"40","author":"Karamian A.","year":"2021","unstructured":"Karamian A.; Paktinat S.; Esfandyari S.; Nazarian H.; Ziai S.A.; Zarnani A.H.; Salehpour S.; Hosseinirad H.; Karamian A.; Novin M.G.; Pyrvinium pamoate induces in-vitro suppression of IL-6 and IL-8 produced by human endometriotic stromal cells. Hum Exp Toxicol  2021,40(4),649-660","journal-title":"Hum Exp Toxicol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s13410-021-00931-x","volume":"41","author":"Mirmiranpour H.","year":"2021","unstructured":"Mirmiranpour H.; Bathaie S.Z.; Khaghani S.; Nakhjavani M.; Kebriaeezadeh A.; L-lysine supplementation improved glycemic control, decreased protein glycation, and insulin resistance in type 2 diabetic patients. Int J Diabetes Dev Ctries  2021,41(4),634-643","journal-title":"Int J Diabetes Dev Ctries"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s10930-011-9353-x","volume":"30","author":"Bathaie S.Z.","year":"2011","unstructured":"Bathaie S.Z.; Nobakht B.B.F.; Mirmiranpour H.; Jafarnejad A.; Moosavi-Nejad S.Z.; Effect of chemical chaperones on glucose-induced lysozyme modifications. Protein J  2011,30(7),480-489","journal-title":"Protein J"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1080\/00021369.1967.10858916","volume":"31","author":"Soda K.","year":"1967","unstructured":"Soda K.; A spectrophotometric microdetermination of keto acids with 3-methyl-2-benzothiazolone hydrazone. Agric Biol Chem  1967,31(9),1054-1060","journal-title":"Agric Biol Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"9607","DOI":"10.1002\/fsn3.4538","volume":"12","author":"Grasset E.","year":"2024","unstructured":"Grasset E.; Briand F.; Virgilio N.; Sch\u00f6n C.; Wilhelm M.; Cudennec B.; Ravallec R.; Aboubacar H.; Vleminckx S.; Prawitt J.; Sulpice T.; Gevaert E.; A specific collagen hydrolysate improves postprandial glucose tolerance in normoglycemic and prediabetic mice and in a first proof of concept study in healthy, normoglycemic and prediabetic humans. Food Sci Nutr  2024,12(11),9607-9620","journal-title":"Food Sci Nutr"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1089\/jmf.2016.3711","volume":"19","author":"Iba Y.","year":"2016","unstructured":"Iba Y.; Yokoi K.; Eitoku I.; Goto M.; Koizumi S.; Sugihara F.; Oyama H.; Yoshimoto T.; Oral administration of collagen hydrolysates improves glucose tolerance in normal mice through GLP-1-dependent and GLP-1-independent mechanisms. J Med Food  2016,19(9),836-843","journal-title":"J Med Food"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1017\/S0007114525103851","volume":"134","author":"Reynolds K.M.","year":"2025","unstructured":"Reynolds K.M.; Hansell E.J.; Thorley J.; Funnell M.P.; Thackray A.E.; Stensel D.J.; Bailey S.J.; James L.J.; Prawitt J.; Virgilio N.; Clifford T.; The effects of collagen peptide supplementation on appetite and post-exercise energy intake in females: a randomised controlled trial. Br J Nutr  2025,134(4),265-276","journal-title":"Br J Nutr"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3390\/md19100584","volume":"19","author":"Sasaoka Y.","year":"2021","unstructured":"Sasaoka Y.; Takagi T.; Michiba S.; Yamamoto Y.; Kumagai Y.; Kishimura H.; Study on the mechanism of the blood-glucose-lowering effect of collagen peptides from sturgeon by-products. Mar Drugs  2021,19(10),584","journal-title":"Mar Drugs"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/bbb\/zbad065","volume":"87","author":"Koizumi S.","year":"2023","unstructured":"Koizumi S.; Okada Y.; Miura S.; Imai Y.; Igase K.; Ohyagi Y.; Igase M.; Ingestion of a collagen peptide containing high concentrations of prolyl-hydroxyproline and hydroxyprolyl-glycine reduces advanced glycation end products levels in the skin and subcutaneous blood vessel walls: a randomized, double-blind, placebo-controlled study. Biosci Biotechnol Biochem  2023,87(8),883-889","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1006\/jsbi.1998.3977","volume":"122","author":"Ramshaw J.A.M.","year":"1998","unstructured":"Ramshaw J.A.M.; Shah N.K.; Brodsky B.; Gly-X-Y tripeptide frequencies in collagen: a context for host-guest triple-helical peptides. J Struct Biol  1998,122(1-2),86-91","journal-title":"J Struct Biol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3109\/09637480903257711","volume":"61","author":"Ichikawa S.","year":"2010","unstructured":"Ichikawa S.; Morifuji M.; Ohara H.; Matsumoto H.; Takeuchi Y.; Sato K.; Hydroxyproline-containing dipeptides and tripeptides quantified at high concentration in human blood after oral administration of gelatin hydrolysate. Int J Food Sci Nutr  2010,61(1),52-60","journal-title":"Int J Food Sci Nutr"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.foodchem.2011.05.066","volume":"129","author":"Shigemura Y.","year":"2011","unstructured":"Shigemura Y.; Akaba S.; Kawashima E.; Park E.Y.; Nakamura Y.; Sato K.; Identification of a novel food-derived collagen peptide, hydroxyprolyl-glycine, in human peripheral blood by pre-column derivatisation with phenyl isothiocyanate. Food Chem  2011,129(3),1019-1024","journal-title":"Food Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.foodchem.2014.02.091","volume":"159","author":"Shigemura Y.","year":"2014","unstructured":"Shigemura Y.; Kubomura D.; Sato Y.; Sato K.; Dose-dependent changes in the levels of free and peptide forms of hydroxyproline in human plasma after collagen hydrolysate ingestion. Food Chem  2014,159,328-332","journal-title":"Food Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1537338","DOI":"10.3389\/fnut.2025.1537338","volume":"12","author":"Chen N.","year":"2025","unstructured":"Chen N.; Wang N.; Fang Q.; Yu Z.; Hu Y.; Jin J.; Yang S.; Inhibition effect of AGEs formation in vitro by the two novel peptides EDYGA and DLLCIC derived from Pelodiscus sinensis. Front Nutr  2025,12,1537338","journal-title":"Front Nutr"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"138","DOI":"10.24659\/gsr.11.4_138","volume":"11","author":"Yagi M.","year":"2024","unstructured":"Yagi M.; Iida M.; Sakiyama C.; Yonei Y.; Inhibition of advanced glycation endproduct formation in amino acids. Glycative Stress Res  2024,11(4),138-144","journal-title":"Glycative Stress Res"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.3390\/nu12102958","volume":"12","author":"Nasu R.","year":"2020","unstructured":"Nasu R.; Furukawa A.; Suzuki K.; Takeuchi M.; Koriyama Y.; The effect of glyceraldehyde-derived advanced glycation end products on \u03b2-tubulin-inhibited neurite outgrowth in SH-SY5Y human neuroblastoma cells. Nutrients  2020,12(10),2958","journal-title":"Nutrients"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"13246","DOI":"10.1021\/acs.jafc.1c03177","volume":"69","author":"Martin-Morales A.","year":"2021","unstructured":"Martin-Morales A.; Arakawa T.; Sato M.; Matsumura Y.; Mano-Usui F.; Ikeda K.; Inagaki N.; Sato K.; Development of a method for quantitation of glyceraldehyde in various body compartments of rodents and humans. J Agric Food Chem  2021,69(44),13246-13254","journal-title":"J Agric Food Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"111248","DOI":"10.1016\/j.mehy.2023.111248","volume":"183","author":"Takeuchi M.","year":"2024","unstructured":"Takeuchi M.; Suzuki H.; Takeda K.; Sakai-Sakasai A.; Toxic advanced glycation end-products (TAGE) are major structures of cytotoxic AGEs derived from glyceraldehyde. Med Hypotheses  2024,183,111248","journal-title":"Med Hypotheses"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3109\/14756366.2013.858143","volume":"29","author":"Hatanaka T.","year":"2014","unstructured":"Hatanaka T.; Kawakami K.; Uraji M.; Inhibitory effect of collagen-derived tripeptides on dipeptidylpeptidase-IV activity. J Enzyme Inhib Med Chem  2014,29(6),823-828","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jdermsci.2012.02.004","volume":"66","author":"Okawa T.","year":"2012","unstructured":"Okawa T.; Yamaguchi Y.; Takada S.; Sakai Y.; Numata N.; Nakamura F.; Nagashima Y.; Ikezawa Z.; Aihara M.; Oral administration of collagen tripeptide improves dryness and pruritus in the acetone-induced dry skin model. J Dermatol Sci  2012,66(2),136-143","journal-title":"J Dermatol Sci"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.3390\/molecules27092718","volume":"27","author":"Kim J.E.","year":"2022","unstructured":"Kim J.E.; Kwon E.Y.; Han Y.; A collagen hydrolysate containing tripeptides ameliorates sarcopenia in middle-aged mice. Molecules  2022,27(9),2718","journal-title":"Molecules"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"867","DOI":"10.4162\/nrp.2025.19.6.867","volume":"19","author":"Kim C.E.","year":"2025","unstructured":"Kim C.E.; Lee J.S.; Kim Y.H.; Shin Y.C.; Shin S.K.; Kwon E.Y.; Effects of collagen tripeptide supplementation on oxidative stress and mitochondrial function in aging. Nutr Res Pract  2025,19(6),867-879","journal-title":"Nutr Res Pract"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298665432008260403055737","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/252989\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298665432008260403055737","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:53:31Z","timestamp":1778759611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/252989\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298665432008260403055737","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-08-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}